KAO JOHN E 4
4 · Alignment Healthcare, Inc. · Filed Sep 10, 2025
Insider Transaction Report
Form 4
KAO JOHN E
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-09-10$16.23/sh−253,908$4,120,749→ 4,634,678 total - Sale
Common Stock
2025-09-10$16.86/sh−101,110$1,704,260→ 4,533,568 total - Sale
Common Stock
2025-09-10$16.42/sh−180,000$2,954,952→ 1,193,100 total(indirect: See Footnote)
Footnotes (6)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F4]Date of Rule 10b5-1 plan adoption: 03/12/2025
- [F5]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.03 to $16.73. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F6]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.